Immunoneutralization of procalcitonin or its component peptides: a promising treatment of sepsis
- 1 September 2010
- journal article
- comment
- Published by Portland Press Ltd. in Clinical Science
- Vol. 119 (12), 515-517
- https://doi.org/10.1042/cs20100367
Abstract
Sepsis and the severe systemic response syndrome are very common illnesses that are responsible for a great amount of morbidity and death. These closely related conditions are characterized by a remarkable increase in the prohormone ProCT (procalcitonin). ProCT is both a marker of sepsis and a harmful mediator of the disease. In the present issue of Clinical Science, in a study in rats with endotoxin shock, Tavares and Miñano used an antibody to a segment of N-ProCT (aminoprocalcitonin) that is part of the ProCT molecule, and confirmed that immunoneutralization of ProCT saves the animals from this severe illness. Furthermore, they extensively studied the epiphenomena associated with this immunoneutralization.This publication has 10 references indexed in Scilit:
- Immunoneutralization of the aminoprocalcitonin peptide of procalcitonin protects rats from lethal endotoxaemia: neuroendocrine and systemic studiesClinical Science, 2010
- Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic targetBritish Journal of Pharmacology, 2010
- Animal models of sepsis and sepsis-induced kidney injuryJCI Insight, 2009
- Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor® Systemcclm, 2004
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceCritical Care Medicine, 2003
- The Surviving Sepsis Campaign: raising awareness to reduce mortalityCritical Care, 2003
- Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigsCritical Care Medicine, 2002
- Late Immunoneutralization of Procalcitonin Arrests the Progression of Lethal Porcine SepsisSurgical Infections, 2001
- Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsisCritical Care Medicine, 1998
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993